National Academy of Medicine Names a Leader of Mount Sinai’s Arnhold Institute for Global Health to Inaugural Emerging Leaders Program
Sandeep Kishore, MD, PhD, Associate Director, The Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, has been named as a member of The National Academy of Medicine’s (NAM’s) first Emerging Leaders Forum.
NAM’s Emerging Leaders Forum began in 2016 to increase the NAM’s engagement with exceptional early- and mid-career professionals working in biomedical science, health care delivery, health policy, and related fields. The Forum facilitates opportunities for mentorship, collaboration, and innovation between emerging leaders, NAM members, and experts across sectors.
“Dr. Kishore was selected as an inaugural member of the National Academy of Medicine’s Emerging Leaders Forum for his leadership attributes in public health,” said National Academy of Medicine President Victor J. Dzau, MD. “I look forward to engaging Dr. Kishore and other members of the Forum to develop a network of young leaders and catalyze innovative and cross-disciplinary activities addressing some of the most pressing challenges in health and medicine.”
Forum members also provide valuable input and feedback to help shape the priorities of the NAM and sustain the NAM’s impact and reputation as a national leader in advancing knowledge and accelerating progress in science, medicine, policy, and health equity. Dr. Kishore is actively involved in NAM’s program on Clinician Well-being and Resilience.
“I am honored to be part of the National Academy of Medicine’s Emerging Leaders Forum,” said Dr. Kishore. “One of the health challenges I’m particularly focused on solving is how to improve the quality of life, access to care, and health outcomes for people living with multiple chronic conditions. It’s my hope to leverage the opportunities for collaboration, innovation, and idea exchange provided by this forum for maximum impact on elevating care and eliminating health disparities in chronic disease here in the United States, and around the world.”
Dr. Kishore joined The Arnhold Institute for Global Health at Mount Sinai from Yale University to build an action center to create new tools to power today’s analysis, advocacy, and action around chronic disease. Over the past decade, Dr. Kishore has organized the world’s first and largest social network of young health professionals committed to global non-communicable diseases, called the Young Professionals Chronic Disease Network, and has helped modernize the World Health Organization’s Essential Medicines List to expand access to critical treatments. Dr. Kishore is the inaugural Lancet Awardee for Community Service, an MIT Dalai Lama Center Fellow, a Paul and Daisy Soros Fellow, a Fellow of the New York Academy of Medicine, and a term member of the Council on Foreign Relations. His work has been featured in the United Nations General Assembly, TEDMED, the World Health Organization Executive Board, and in journals including Health Affairs, JAMA, The Lancet, Bulletin of the World Health Organization, and Journal of the American College of Cardiology.
“We are thrilled that Dr. Kishore has been selected to be part of NAM’s prestigious and inaugural Emerging Leaders Forum,” said Prabhjot Singh, MD, PhD, Director, The Arnhold Institute for Global Health, and Chair, Department of Health System Design and Global Health, Icahn School of Medicine. “Dr. Kishore’s passion for improving care models at scale for people living with chronic conditions is closely aligned with The Arnhold Institute’s mission to strengthen community health for all people, no matter where they live. We couldn’t be more proud to have Dr. Kishore as an ally in our work.”
Dr. Kishore’s term with NAM’s Emerging Leaders Forum runs through October 2018.
About The Arnhold Institute for Global Health
The Arnhold Institute for Global Health at the Icahn School of Medicine, Mount Sinai Health System, seeks to improve the health of people and the communities they live in, both in the United States and abroad. The Arnhold Institute serves as a global arm of the Mount Sinai Health System, leading research on the design of more equitable and effective care models that are disseminated through digital products, training systems and input on policy design.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, an integrated health care system which includes seven hospitals and an expanding ambulatory network serving approximately 4 million patients per year.
The School has more than 1,800 students in MD, PhD, and Master’s programs and post-doctoral fellowships; more than 5,600 faculty members; over 2,000 residents and fellows; and 23 clinical and research institutes and 34 academic departments. It is ranked among the highest in the nation in National Institutes of Health funding per principal investigator. The School was the first medical school in the country to create a progressive admissions approach for students who seek early assurance of admission through the FlexMed program.
The Graduate School of Biomedical Science trains PhD and MD/PhD students, and offers master’s-level programs in areas such as genetic counseling, clinical research, biomedical sciences, and public health, and an online master’s degree in health care delivery leadership. The seamless connections between our medical school, graduate school, and hospital campuses provide an extraordinary environment for translating scientific discoveries into clinical treatments.
For more information, visit http://icahn.mssm.edu or find the Icahn School of Medicine at Mount Sinai on Facebook, Twitter, YouTube, and LinkedIn.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The System includes approximately 6,600 primary and specialty care physicians; 10 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 13 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke's and Mount Sinai West are ranked regionally.